Give the Covid vaccine to healthy young people first
Skip to main content
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
The Business Standard

Tuesday
February 07, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Fact Check
    • Family
    • Food
    • Game Reviews
    • Good Practices
    • Habitat
    • Humour
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wealth
    • Wellbeing
    • Wheels
  • Epaper
  • More
    • Subscribe
    • Videos
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Games
    • Long Read
    • Interviews
    • Offbeat
    • Podcast
    • Quiz
    • Tech
    • Trial By Trivia
    • Magazine
  • বাংলা
TUESDAY, FEBRUARY 07, 2023
Give the Covid vaccine to healthy young people first

Analysis

Faye Flam, Bloomberg
15 August, 2020, 08:50 pm
Last modified: 15 August, 2020, 10:01 pm

Related News

  • Pandemic to paradise: Chinese tourists return to Bali after three years
  • Dialysis patients have a 50% mortality risk from Covid: BSMMU study
  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement

Give the Covid vaccine to healthy young people first

Slowing the spread is the best way to protect the elderly and immunocompromised

Faye Flam, Bloomberg
15 August, 2020, 08:50 pm
Last modified: 15 August, 2020, 10:01 pm
Disinfectants and masks help but a vaccine would be better. Photo: Ali Al-Daher/AFP/Getty Images/Bloomberg
Disinfectants and masks help but a vaccine would be better. Photo: Ali Al-Daher/AFP/Getty Images/Bloomberg

Who should be at the front of the line if an effective Covid-19 vaccine emerges from testing? The answer depends on what we learn from the kind of field trials Russia is skipping.

Some vaccines might not be that good at preventing infection, but would prevent severe cases. Those should be given to those most likely to die from the disease — older people or those with conditions associated with death from Covid-19.

But if a vaccine actually prevents transmission, then priority should go to those who transmit the disease most often:  younger adults. Getting protected with a vaccine is a way of protecting others, since you can't give anyone the disease if you never get it. And starting with younger people could be the fastest route to herd immunity — that phenomenon by which the virus is slowed by a lack of susceptible hosts.

Why give the vaccine to the people most likely to spread the disease rather than to the people most likely to die from it?  Virologist David Sanders of Purdue explains that it's likely that Covid-19 vaccines it won't work as well in people with poorly functioning immune systems — those most vulnerable to the disease. That's often the case with flu shots and other vaccines. But those people can still be protected if enough healthy people get vaccinated to drive infections way down. "Immunization is not about protecting the individual — it's about protecting society," he says.

But here's the rub: If young, healthy people unlikely to die from the disease are being asked to step up and get vaccinated, the odds of any serious side effects have to be extremely low. And that's why field testing is so important.

Skipping that kind of extensive field testing, as Russia is doing, could foil our chance to end the pandemic. Infectious disease specialist Paul Offit of the Children's Hospital of Philadelphia says the early phases of the FDA's required testing offer limited information. Phase 1 determines the optimal dose for a vaccine. Phase 2 enrolls hundreds of people, which can reveal common side effects and determine whether the vaccine prompts the body's immune system to produce antibodies or T-cells capable of disabling the virus.

Those early trials have already revealed transient side effects, especially fever and the malaise that goes with it. But given the number of people dying from the disease, that's probably going to be considered tolerable.

Phase 3 is the time-consuming part, where a vaccine is compared to a placebo in the real world. Even with the expected 30,000 volunteers for each of several front runners, that could take a few months, depending on how much transmission is going on. At least a few people in the placebo group need to get infected to demonstrate efficacy.

This is the phase Russia is skipping, and it's only during this phase that researchers can tell if people who get vaccinated can still develop a mild or silent infection and transmit to others. The vaccines generally prompt your body to produce antibodies to just one of the viral proteins, but the virus makes four proteins, and a natural infection will leave you with distinct, detectable antibodies to all of them.

Still, even enrolling tens of thousands of people in those trials may not be enough to reveal rare side effects, says Offit. The live polio vaccine caused a few children to get polio — about 1 in 2.4 million. A swine flu vaccine deployed in 1976 caused a rare neurological disorder called Guillain-Barré Syndrome. About one in 100,000 people developed the condition, and while most recovered, a few died or suffered permanent paralysis. A further data-gathering phase — sometimes called Phase 4 — would have a better chance of catching anything that rare, and reduce any risk that a vaccine could hurt the healthy people being asked to get it.

Phase 4 isn't part of the testing regimen required for licensure, but refers to post-licensure surveillance , said Harvard public health professor Barry Bloom, speaking at a Zoom press conference. Purdue's Sanders says this phase should include health care workers and military personnel, since they can be closely tracked to provide crucial information.

It might seem counterintuitive to do extra testing in a situation this urgent it has prompted Russia to deploy a vaccine without the critical field testing the FDA requires. But additional testing wouldn't have to slow down the benefits of a vaccine. Think of it as a hybrid between a final trial and the rollout itself, configured to gather important data.

This additional layer of testing could help prevent problems that might get in the way of widespread adoption of a Covid-19 vaccine. Offit says he's worried that people will come to believe in severe side effects that don't exist. Out of the millions who eventually get the vaccine, a few will likely have heart attacks or strokes or develop multiple sclerosis or some other disease that wasn't caused by the vaccine but happened close enough in time to seem that way. Such temporal associations, as he calls them, have created the longstanding, false perception that childhood vaccines caused autism.

A Phase 4 trial could prevent these problems, and help convince enough healthy, young people — those with the least to individually gain from a vaccine — that getting a coronavirus vaccine is both safe and their civic duty.


Faye Flam is a Bloomberg Opinion columnist. She has written for the Economist, the New York Times, the Washington Post, Psychology Today, Science and other publications. She has a degree in geophysics from the California Institute of Technology.

Disclaimer: This article first appeared on bloomberg.com, and is published by special syndication arrangement.

 

Top News

Covid / Vaccine

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Infographic: TBS
    FDI from US halves in January-June 2022
  • A woman reacts while embracing another person, near rubble following an earthquake in Hatay, Turkey, February 7, 2023. REUTERS/Umit Bektas
    Earthquake deaths cross 4,800 in Turkey, Syria; severe weather hampers rescue operations
  • Photo: TBS
    BNP to hold march programmes in Dhaka on 9 and 12 February

MOST VIEWED

  • People stand in front of collapsed buildings following an earthquake in Kahramanmaras, Turkey, 3 February, 2023. Photo: Reuters
    Why is Turkey an earthquake hot spot?
  • The megaproject Rooppur Nuclear Power Plant has a debt of Tk90,474 crore. Photo: Courtesy
    Projects funded with debt need to be selected prudently, and implemented timely
  • Some tough tasks on the plate for Bangladesh Bank!
    Some tough tasks on the plate for Bangladesh Bank!
  • Having sufficient reserves, strong social security needed to be safe in bad time
    Having sufficient reserves, strong social security needed to be safe in bad time
  • Resilience should be built to cope with long-term implications
    Resilience should be built to cope with long-term implications
  • Why 2012 reforms were not done is a million-dollar question
    Why 2012 reforms were not done is a million-dollar question

Related News

  • Pandemic to paradise: Chinese tourists return to Bali after three years
  • Dialysis patients have a 50% mortality risk from Covid: BSMMU study
  • Rally, scientific seminar to prevent cervical cancer held at Labaid Hospital
  • Updated Covid vaccines prevented illness from latest variants -CDC
  • Vaccine misinformation spawns 'pure blood' movement

Features

Nimah designed by Compass Architects- Wooden tiles. Photo: Junaid Hasan Pranto

Trendy flooring designs to upgrade any space

4h | Habitat
Benefits of having high ceilings in your new home

Benefits of having high ceilings in your new home

3h | Habitat
Each Reverse Osmosi plant can produce approximately 8,000 litres of drinking water a day for around 250 families. Photo: Sadiqur Rahman

A drop in the ocean of persistent water crisis

5h | Panorama
Photo: Collected

Get your partner a lovely present this Valentine's Day

1d | Brands

More Videos from TBS

Challenging time waiting for RMG

Challenging time waiting for RMG

2h | TBS Round Table
"Full Moon Meditation" organized by Department of Theater and Performance Studies, University of Dhaka

"Full Moon Meditation" organized by Department of Theater and Performance Studies, University of Dhaka

2h | TBS Graduates
10 cricketers who have played over 400 T20 matches

10 cricketers who have played over 400 T20 matches

2h | TBS SPORTS
Harry Kane sets two record in one goal

Harry Kane sets two record in one goal

2h | TBS SPORTS

Most Read

1
Photo: Courtesy
Panorama

From 'Made in Bangladesh' to 'Designed in Bangladesh'

2
Leepu realised his love for cars from a young age and for the last 40 years, he has transformed, designed and customised hundreds of cars. Photo: Collected
Panorama

'I am not crazy about cars anymore': Nizamuddin Awlia Leepu

3
Master plan for futuristic Chattogram city in the making
Districts

Master plan for futuristic Chattogram city in the making

4
The International Monetary Fund (IMF) logo is seen outside the headquarters building in Washington, U.S., September 4, 2018. REUTERS/Yuri Gripas/File Photo
Economy

IMF approves $4.7 billion loan for Bangladesh, calls for ambitious reforms

5
Belal Ahmed new acting chairman of SIBL
Banking

Belal Ahmed new acting chairman of SIBL

6
Photo: Collected
Crime

Prime Distribution MD Mamun arrested in fraud case

EMAIL US
[email protected]
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]